Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Endometriosis Strategic Business Report 2018 with Major Drugs Lupron, Zoladex, Synarel - Analysis and Forecasts 2012-2022 -

Research and Markets
Posted on: 20 Feb 18

The "Endometriosis - Global Strategic Business Report" report has been added to's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022.

Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report analyzes the worldwide markets for Endometriosis in US$ Million.

The report profiles 38 companies including many key and niche players such as:

  • AbbVie Inc. (US)
  • AEterna Zentaris Inc. (Canada)
  • Astellas Pharma Inc. (Japan)
  • AstraZeneca Plc. (UK)
  • Bayer HealthCare Pharmaceuticals, Inc. (US)
  • Debiopharm Group (Switzerland)
  • Evotec AG (Germany)
  • Kissei Pharmaceutical Co., Ltd. (Japan)
  • Neurocrine Biosciences, Inc. (US)
  • ObsEva SA (Switzerland)
  • Pfizer, Inc. (US)
  • Repros Therapeutics, Inc. (US)
  • Roivant Sciences Ltd. (US)
  • Takeda Pharmaceutical Company Limited (Japan)
  • ValiRx Plc (UK)

Key Topics Covered:

I. Introduction, Methodology & Product Definitions

II. Executive Summary

1. Industry Overview

2. Endometriosis & Its Treatment - An Overview

3. Treatment of Endometriosis

4. Select Clinical Trials/Product Innovations & Approvals

5. Recent Industry Activity

6. Focus on Select Global Players

7. Global Market Perspective

Total Companies Profiled: 38 (including Divisions/Subsidiaries 40)

The United States (11)

Canada (3)

Japan (6)

Europe (15)

- France (1)

- Germany (3)

- The United Kingdom (2)

- Rest of Europe (9)

Asia-Pacific (Excluding Japan) (3)

Middle East (1)

Latin America (1)

For more information about this report visit

View source version on

Business Wire

Last updated on: 20/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.